Advocacy Wealth Management Services’s Clovis Oncology, Inc. CLVS Stock Holding History

Advocacy Wealth Management Services’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-200	Closed	-$4K	–	179
2018 Q4	$4K	Hold	200	–	–	﹤0.01%	143
2018 Q3	$6K	Hold	200	–	–	﹤0.01%	152
2018 Q2	$9K	Hold	200	–	–	0.01%	139
2018 Q1	$11K	Hold	200	–	–	0.01%	133
2017 Q4	$14K	Hold	200	–	–	0.01%	137
2017 Q3	$16K	Hold	200	–	–	0.01%	152
2017 Q2	$19K	Hold	200	–	–	0.01%	137
2017 Q1	$13K	Hold	200	–	–	﹤0.01%	181
2016 Q4	$9K	Hold	200	–	–	﹤0.01%	216
2016 Q3	$7K	Hold	200	–	–	﹤0.01%	301
2016 Q2	$3K	Hold	200	–	–	﹤0.01%	367
2016 Q1	$4K	Hold	200	–	–	﹤0.01%	434
2015 Q4	$7K	Buy	+200	New	+$12.9K	0.01%	398

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advocacy Wealth Management Services's CLVS Position: Q1 2019 in Review

Advocacy Wealth Management Services sold out of Clovis Oncology, Inc. (CLVS) in Q1 2019, closing a stake of 200 shares — an estimated $4K sold.

Advocacy Wealth Management Services first reported a position in CLVS in Q4 2015 and held it in 13 quarters. The position peaked at $19K in Q2 2017. 186 funds tracked by Wall St. Rank hold CLVS as of Q1 2019.

Advocacy Wealth Management Services reported no remaining Clovis Oncology, Inc. position as of Q1 2019 after selling out during the quarter.
Advocacy Wealth Management Services sold 200 Clovis Oncology, Inc. shares in Q1 2019, an estimated $4K.
Advocacy Wealth Management Services first reported a position in Clovis Oncology, Inc. in Q4 2015 and held it in 13 quarters.
Advocacy Wealth Management Services's Clovis Oncology, Inc. position peaked at $19K in Q2 2017.
186 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2019.

Based on Advocacy Wealth Management Services's 13F filing for Q1 2019, filed 2 Apr 2019.